Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0641
D

Incorrect MDS Coding for Insulin Administration

Kenesaw, Nebraska Survey Completed on 08-26-2025

Penalty

5 days payment denial
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to accurately code the Minimum Data Set (MDS) for two of seventeen sampled residents, as required by federal and state regulations. Specifically, the MDS for both residents was coded to indicate that they had received insulin injections during the 7-day look back period. However, a review of the Medication Administration Records (MAR) for both residents showed no documented administrations of insulin during that time frame. Instead, the records indicated that the residents had received other injectable medications for Type 2 Diabetes—Trulicity and Ozempic—which are not classified as insulin. The Minimum Data Set Coordinator (MDSC) confirmed during an interview that the residents did not receive insulin during the assessment period and acknowledged that the MDS coding was incorrect. The coding error was attributed to the misclassification of non-insulin injectable diabetes medications as insulin in the MDS documentation. This discrepancy was identified through record review and staff interview, confirming that the facility did not follow the correct coding instructions as outlined in the Resident Assessment Instrument (RAI) Manual.

An unhandled error has occurred. Reload 🗙